Targeting the IL-17A pathway for therapy in early-stage tendinopathy

Targeting the IL-17A pathway for therapy in early-stage tendinopathy

Objectives Tendinopathy is a frequent clinical problem and represents an extraordinary health economic and socioeconomic burden with high unmet medical needs. Recent clinical evidence suggests blockade of interleukin 17A (IL-17A) for tendinopathy therapy. The present preclinical study elucidates the...

Full description

Saved in:
Bibliographic Details
Main Authors: Iain B McInnes, Richard M Siegel, Neal L Millar, Moeed Akbar, Michaela Kneissel, Frank Kolbinger, Friedrich Raulf, Yufei Li, Nicolau Beckmann, Nathalie Accart, Olivier Leupin, Claudio Calonder, Matthias Schieker, Christian Bruns, Eckhard Weber
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/11/1/e004729.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rmdopen.bmj.com/content/11/1/e004729.full

Similar Items